scispace - formally typeset
Search or ask a question
Institution

Medical Research Council

GovernmentLondon, United Kingdom
About: Medical Research Council is a government organization based out in London, United Kingdom. It is known for research contribution in the topics: Population & Malaria. The organization has 16430 authors who have published 19150 publications receiving 1475494 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The results showed that in brain tissue incubated under the conditions used, the organization underlying metabolic compartmentation was preserved and the observed concentration ratios of amino acids between tissue and medium were also similar to those obtaining in vivo.
Abstract: 1. Cerebral-cortex slices prelabelled with gamma-amino[1-(14)C]butyrate (GABA) were incubated in a glucose-saline medium. After the initial rapid uptake there was no appreciable re-entry of (14)C into the GABA pool, either from the medium or from labelled metabolites formed in the tissue. The kinetic constants of GABA metabolism were determined by computer simulation of the experimental results by using mathematical procedures. The GABA flux was estimated to be 0.03mumol per min/g, or about 8% of the total flux through the tricarboxylic acid cycle. It was found that the assumption of compartmentation did not greatly affect the estimates of the GABA flux. 2. The time-course of incorporation of (14)C into amino acids associated with the tricarboxylic acid cycle was followed with [1-(14)C]GABA and [U-(14)C]-glucose as labelled substrates. The results were consistent with the utilization of GABA via succinate. This was confirmed by determining the position of (14)C in the carbon skeletons of aspartate and glutamate formed after the oxidation of [1-(14)C]GABA. These results also indicated that under the experimental conditions the reversal of reactions catalysed by alpha-oxoglutarate dehydrogenase and glutamate decarboxylase respectively was negligible. The conversion of [(14)C]GABA into gamma-hydroxybutyrate was probably also of minor importance, but decarboxylation of oxaloacetate did occur at a relatively slow rate. 3. When [1-(14)C]GABA was the labelled substrate there was evidence of a metabolic compartmentation of glutamate since, even before the peak of the incorporation of (14)C into glutamate had been reached, the glutamine/glutamate specific-radioactivity ratio was greater than unity. When [U-(14)C]glucose was oxidized this ratio was less than unity. The heterogeneity of the glutamate pool was indicated also by the relatively high specific radioactivity of GABA, which was comparable with that of aspartate during the whole incubation time (40min). The rates of equilibration of labelled amino acids between slice and medium gave evidence that the permeability properties of the glutamate compartments labelled as a result of oxidation of [1-(14)C]GABA were different from those labelled by the metabolism of [(14)C]glucose. The results showed therefore that in brain tissue incubated under the conditions used, the organization underlying metabolic compartmentation was preserved. The observed concentration ratios of amino acids between tissue and medium were also similar to those obtaining in vivo. These ratios decreased in the order: GABA>acidic acids>neutral amino acids>glutamine. 4. The approximate pool sizes of the amino acids in the different metabolic compartments were calculated. The glutamate content of the pool responsible for most of the labelling of glutamine during oxidation of [1-(14)C]GABA was estimated to be not more than 30% of the total tissue glutamate. The GABA content of the ;transmitter pool' was estimated to be 25-30% of the total GABA in the tissue. The structural correlates of metabolic compartmentation were considered.

303 citations

Journal Article
01 Jan 1991-BMJ
TL;DR: A new trial comparing cisplatin, doxorubicin, and cyclophosphamide with carboplatin has been launched and plans to accrue 2000 patients, suggesting the degree of benefit suggested is realistic for currently available chemotherapeutic regimens.
Abstract: OBJECTIVES--To consider the role of platinum and the relative merits of single agent and combination chemotherapy in the treatment of advanced ovarian cancer. DESIGN--Formal quantitative overview using updated individual patient data from all available randomised trials (published and unpublished). SUBJECTS--8139 patients (6408 deaths) included in 45 different trials. RESULTS--No firm conclusions could be reached. Nevertheless, the results suggest that in terms of survival immediate platinum based treatment was better than non-platinum regimens (overall relative risk 0.93; 95% confidence interval 0.83 to 1.05); platinum in combination was better than single agent platinum when used in the same dose (overall relative risk 0.85; 0.72 to 1.00); and cisplatin and carboplatin were equally effective (overall relative risk 1.05; 0.94 to 1.18). CONCLUSIONS--In the past, randomised clinical trials of chemotherapy in advanced ovarian cancer have been much too small to detect the degree of benefit which this overview suggests is realistic for currently available chemotherapeutic regimens. Hence a new trial comparing cisplatin, doxorubicin, and cyclophosphamide (CAP) with carboplatin has been launched and plans to accrue 2000 patients.

303 citations

Journal ArticleDOI
TL;DR: The study design, methods and baseline findings of a behavioural intervention trial aimed at reducing HIV incidence are described, with a clear focus on reducing infection in women.
Abstract: The objective was to describe the study design methods and baseline findings of a behavioural intervention trial aimed at reducing HIV incidence A cluster randomized-controlled trial (RCT) conducted in 70 villages in rural South Africa A behavioural intervention Stepping Stones was implemented in 35 communities in two workshops of 20 men and 20 women in each community who met for 17 sessions (50 h) over a period of 3-12 weeks Individuals in the control arm communities attended a single session of about 3 h on HIV and safer sex Impact assessment was conducted through two questionnaire and serological surveys at 12-month intervals The primary outcome was HIV incidence and secondary measures included changes in knowledge attitude and sexual behaviours Qualitative research was also undertaken with 10 men and 10 women from two sites receiving the intervention (one rural and one urban) and five men and five women from one village in the control arm They were interviewed individually three times prior to the workshops and then 9-12 months later A total of 2776 participants (1409 intervention and 1367 control) were enrolled at baseline and had an interview and HIV sero-status was established HIV baseline prevalence rates in women were 98% in the intervention arm and 128% in the control arm In men the prevalence was 17% in the intervention arm and 21% in the control arm Demographic and behavioural characteristics were similar in the two arms In the intervention groups 599% of participants attended more than 75% of the sessions In the control group 663% attended the control session This is the third RCT to be conducted in sub-Saharan Africa evaluating a behavioural intervention using HIV incidence as a primary outcome It is of particular interest as the intervention in question is used in many developing countries There is good baseline comparability between the study arms and the process data on the workshops suggested that the interventions were feasible and adequately implemented (authors)

302 citations

Journal ArticleDOI
TL;DR: Pyridine hemochrome spectra suggest that the hemes of cytochrome bo are not protohemes, and optical spectra indicate that high-spin heme o contributes less than 10% to the reduced minus oxidized 560-nm band of the enzyme.
Abstract: Proton translocation coupled to oxidation of ubiquinol by O{sub 2} was studied in spheroplasts of two mutant strains of Escherichia coli, one of which expresses cytochrome d, but not cytochrome bo, and the other expressing only the latter. O{sub 2} pulse experiments revealed that cytochrome d catalyzes separation of the protons and electrons of ubiquinol oxidation but is not a proton pump. In contrast, cytochrome bo functions as a proton pump in addition to separating the charges of quinol oxidation. E. coli membranes and isolated cytochrome bo lack the Cu{sub A} center typical of cytochrome c oxidase, and the isolated enzyme contains only 1Cu/2Fe. Optical spectra indicate that high-spin heme o contributes < 10% to the reduced minus oxidized 560-nm band of the enzyme. Pyridine hemochrome spectra suggest that the hemes of cytochrome bo are not protohemes. Proteoliposomes with cytochrome bo exhibited good respiratory control, but H{sup +}/e{sup {minus}} during quinol oxidation was only 0.3-0.7. This was attributed to an inside out orientation of a significant fraction of the enzyme. Possible metabolic benefits of expressing both cytochromes bo and d in E. coli are discussed.

302 citations

Journal ArticleDOI
01 Apr 1994-Lingua
TL;DR: This paper examined the interaction between a conceptual influence (the bias to interpret observed situations as involving a casual agent) and syntactic influences, as these jointly contribute to children's conjectures about new verb meanings.

302 citations


Authors

Showing all 16441 results

NameH-indexPapersCitations
Shizuo Akira2611308320561
Trevor W. Robbins2311137164437
Richard A. Flavell2311328205119
George Davey Smith2242540248373
Nicholas J. Wareham2121657204896
Cyrus Cooper2041869206782
Martin White1962038232387
Frank E. Speizer193636135891
Michael Rutter188676151592
Richard Peto183683231434
Terrie E. Moffitt182594150609
Kay-Tee Khaw1741389138782
Chris D. Frith173524130472
Phillip A. Sharp172614117126
Avshalom Caspi170524113583
Network Information
Related Institutions (5)
National Institutes of Health
297.8K papers, 21.3M citations

94% related

University of California, San Francisco
186.2K papers, 12M citations

92% related

Karolinska Institutet
121.1K papers, 6M citations

92% related

French Institute of Health and Medical Research
174.2K papers, 8.3M citations

92% related

Johns Hopkins University School of Medicine
79.2K papers, 4.7M citations

92% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20236
20229
2021262
2020243
2019231
2018309